rxstat › Shortages › Lurasidone
Lurasidone (Latuda) shortage status
Partial shortage
An antipsychotic used to treat schizophrenia and bipolar depression.
Shortage history
Reports by product
What's happening
Lurasidone is currently affected by an active shortage report filed with Health Canada by TARO PHARMACEUTICALS INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Lurasidone is classified under “ANTIPSYCHOTICS” (ATC N05AE).
Recent changes
- Oct 29, 2026 Estimated end date pushed back : Oct 30, 2026 → Dec 24, 2026
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Shortage resolved
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Oct 27, 2026 Status changed
- Sep 4, 2026 Estimated end date pushed back : Oct 2, 2026 → Oct 30, 2026
- Aug 26, 2026 Estimated end date pushed back : Aug 28, 2026 → Sep 4, 2026
- Aug 17, 2026 New report filed
- Aug 17, 2026 Estimated end date pushed back : Aug 21, 2026 → Aug 28, 2026
- Aug 5, 2026 Estimated end date pushed back : Aug 7, 2026 → Aug 21, 2026
- Jul 29, 2026 Estimated end date pushed back : Jul 24, 2026 → Aug 7, 2026
- Jul 14, 2026 Estimated end date pushed back : Jun 19, 2026 → Jul 24, 2026
Common questions
What is Lurasidone used for?
An antipsychotic used to treat schizophrenia and bipolar depression.
When will Lurasidone be back in stock in Canada?
The latest manufacturer estimate is Dec 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Lurasidone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Possible alternatives in the same class (antipsychotics)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.